16
Participants
Start Date
July 31, 2009
Primary Completion Date
September 30, 2009
Study Completion Date
July 31, 2010
Oral testosterone undecanoate (containing 300 mg T)
LABiomedical Research Institute at Harbor-UCLA Medical Center, Torrance
Anapharm, Inc., Québec
Lead Sponsor
Clarus Therapeutics, Inc.
INDUSTRY